Acne is one of the most common skin conditions seen in general practice. Acne vulgaris – the most prevalent form – affects more than 80% of teenagers and young adults (in some countries, it may be as ...

The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. GLP-1 receptor agonist users were 1.36 times more likely ...

Acne vulgaris remains one of the most pervasive inflammatory skin conditions worldwide, affecting not only adolescents but also adults and contributing to significant psychosocial burden. The ...

Please provide your email address to receive an email when new articles are posted on . Acne vulgaris may be driven by underlying systemic, immune-inflammatory pathways. Addressing those underlying ...

Sagimet Biosciences' partner Ascletis reported strong phase 3 results for denifanstat in moderate-to-severe acne, validating FASN inhibition as a novel oral treatment. Sagimet is advancing next-gen ...